Latest News

Date Title Topic
17 Jan 2020 New consensus manuscript
17 Jan 2020 ESMO Releases New Patient Guide in Biliary Tract Cancer Gastrointestinal cancers
16 Jan 2020 Redesigned ESMO websites on their way
16 Jan 2020 Immune Checkpoint Inhibitors Associated with Lower Risk of Developing Severe and Any Adverse Events Compared to Chemotherapy Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
15 Jan 2020 Crizotinib in NSCLC With a MET Exon 14 Alteration Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
14 Jan 2020 EMA Recommends Granting Marketing Authorisation for Azacitidine Accord Haematologic malignancies - Anticancer agents & Biologic therapy
13 Jan 2020 FDA Approves Avapritinib for GIST with a PDGFRA Exon 18 Mutation Sarcomas - Personalised medicine - Anticancer agents & Biologic therapy
10 Jan 2020 EMA Recommends Extension of Therapeutic Indications for Daratumumab Haematologic malignancies - Anticancer agents & Biologic therapy
09 Jan 2020 New Treatment Recommendation
09 Jan 2020 FDA Approves Pembrolizumab for BCG-Unresponsive, High-Risk Non-Muscle Invasive Bladder Cancer Genitourinary cancers - Cancer Immunology and Immunotherapy
08 Jan 2020 Oligometastatic Disease Classification Cancer in Special Situations / Population
07 Jan 2020 ESMO Clinical Practice Guidelines: Marginal Zone Lymphomas
07 Jan 2020 FDA Approves Olaparib for Germline BRCA-mutated Metastatic Pancreatic Adenocarcinoma Gastrointestinal cancers - Personalised medicine - Anticancer agents & Biologic therapy
03 Jan 2020 FDA Approves Enzalutamide for Metastatic Castration-Sensitive Prostate Cancer Genitourinary cancers - Anticancer agents & Biologic therapy
20 Dec 2019 New topic!